Who
Gregory George
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, Mesoblast.
In numbers
- Trades disclosed
- 60
- Buys
- 6
- Sells
- 0
- Bought
- $75.1M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 4 Apr 2026
- Last trade
- 10 Apr 2026
- Last filed
- 13 Apr 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $3.4M2,324,072 at $1.48 | filing |
| 10 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $3.4M2,324,072 at $1.48 | filing |
| 10 Apr 2026filed 10 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $3.4M2,324,072 at $1.48 | filing |
| 10 Apr 2026filed 10 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $3.4M2,324,072 at $1.48 | filing |
| 9 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $14K10,000 at $1.43 | filing |
| 9 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $7,1505,000 at $1.43 | filing |
| 9 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $14K10,000 at $1.43 | filing |
| 9 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $14K10,000 at $1.43 | filing |
| 9 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $14K10,000 at $1.41 | filing |
| 9 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $1.3M886,890 at $1.43 | filing |
| 9 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $153K105,000 at $1.46 | filing |
| 9 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $720K500,000 at $1.44 | filing |
| 9 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $14K10,000 at $1.44 | filing |
| 9 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $6,8544,760 at $1.44 | filing |
| 9 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $29K20,000 at $1.43 | filing |
| 9 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $14K10,000 at $1.43 | filing |
| 9 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $1.3M886,890 at $1.43 | filing |
| 9 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $153K105,000 at $1.46 | filing |
| 9 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $720K500,000 at $1.44 | filing |
| 9 Apr 2026filed 13 Apr 2026 | MESO MesoblastBiotechnology | SEC FORM 4 Bought | $14K10,000 at $1.44 | filing |
News
No headline names them, or the companies they trade most, lately.